publication . Article . 2008

Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in Colombia

Andres-Gamboa, O.; Chicaiza, L.; Mario Garcia-Molina; Diaz, J.; Gonzalez, M.; Murillo, R.; Ballesteros, M.; Sanchez, R.;
  • Published: 01 Aug 2008
Abstract
OBJECTIVE: To assess cost-effectiveness of conventional cytology and HPV DNA testing for cervical-cancer screening in Colombia. MATERIAL AND METHODS: The National Cancer Institute of Colombia (NCIC) in 2007 developed a Markov model on the natural history of cervical cancer; no screening, conventional cytology, and HPV DNA testing were compared. Only direct costs were used. Outcomes comprise cervical cancer mortality, years of life saved, and lifetime costs. Discounted incremental cost-effectiveness ratios were estimated and sensitivity analyses were conducted for key parameters. RESULTS: Depending on the screening strategy a 69-81% mortality reduction might be e...
Subjects
free text keywords: uterine cervical neoplasms, cost-benefit analysis, mass screening, Colombia, neoplasias del cuello uterino, tamizaje masivo, análisis costo-beneficio
40 references, page 1 of 3

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5 version 2.0. Lyon: IARC Press,2004.

2. Lynge E, Madsen M, Engholm G. Effect of organised screening on incidence and mortality of cervical cancer in Denmark. Cancer Res 1989; 49(8): 2157-2160. [OpenAIRE]

3. Neto JE, Ramalho CM. Cervical Cancer in Laitn America. Semin Oncol 2001; 28(2):188-197.

4. Pineros M, Hernandez G, Bray F. Increasing mortality rates of common malignancies in Colombia: an emerging problem. Cancer 2004;101(10):2285-2292.

5. Goldie SJ. Chapter 15: Public health policy and cost-effectiveness analysis. J Natl Cancer Inst Monogr 2003; 31: 102-110 [OpenAIRE]

6. Goldie SJ, Gaffikin L, Goldhaber JD, Gordillo A, Levin C,Wright T, et al. Cost-Effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005; 353:2158-2168.

7. Goldie SJ, Kuhn L, Denny L, Pollack A,Wright T. Policy analysis of cervical cancer screening strategies in low-resource settings. JAMA 2001; 285(24): 3107-3126. [OpenAIRE]

8. Legood R, Gray A, Mahé C, Javant k, Nene BM, Sankaranarayanan R, et al. Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. Int J Cancer 2005; 117: 981-987.

9. Holmes J, Hemmett L, Garfield S.The cost-effectiveness of human papillomavirus screening for cervical cancer. Eur J Health Econom 2005; 50: 30-37.

10. Flores Y, Bishai D, Lazcano E, Shah K, Lörincz A, Hernández M, et al. Improving cervical cancer screening in Mexico: results from the Morelos HPV Study. Salud Publica Mex 2003;45 Suppl 3:S388-S398.

11. Kim JJ, Leung GM,Woo P, Goldie SJ. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong. J Public Health 2004; 26(2): 130-137.

12. Instituto Nacional de Cancerología. Recomendaciones para la tamización de neoplasias de cuello uterino en mujeres sin antecedentes de patología cervical (preinvasora o invasora) en Colombia. Bogotá: INC, 2007.

13. Prieto L, Sacristán JA,Antoñanzas F,Terrés CR, Pinto JL, Rovira J. Análisis coste-efectividad en la evaluación económica de intervenciones sanitarias. Med Clin (Barc) 2004; 122 (13):505-510. 14.World Health Organization. Macroeconomics and health: investing in health for economic development: report of the Commission on Macroeconomics and Health. Geneva:World Health Organization, 2001.

15. Departamento Administrativo Nacional de Estadística (DANE). Cuentas regionales. [Accesed February 11, 2008]. Available at: www.dane.gov.co/files/investigaciones/pib/departamentales.

16. Departamento Administrativo Nacional de Estadística (DANE). Población: indicadores demográficos según departamento. [Accesed August 31, 2007].Available at: www.dane.gov.co.

40 references, page 1 of 3
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2008

Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in Colombia

Andres-Gamboa, O.; Chicaiza, L.; Mario Garcia-Molina; Diaz, J.; Gonzalez, M.; Murillo, R.; Ballesteros, M.; Sanchez, R.;